Drug News
Women More Often Treated with Low-Dose Dabigatran
Despite trend toward lower stroke risk with high dose
Your search for dabigatran returned 38 results
American College of Cardiology 2011
Dabigatran Etexilate vs. Warfarin in Different Types of Atrial Fibrillation
A subgroup analysis from the RE-LY trial has demonstrated that in patients with atrial fibrillation (AF), twice-daily dabigatran etexilate has better efficacy and lower rates of major bleeding when compared with warfarin, as reported at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.
News
Dabigatran Combined with Certain Statins May Up Hemorrhage Risk in A-Fib Patients
Combining dabigatran with certain statin medications could raise the odds for major hemorrhage in patients with atrial fibrillation, according to a study published online in CMAJ, the journal of the Canadian Medical Association.
News
Stimulated Reporting Accounts for High Dabigatran Bleeding
The increased number of post-marketing reports of bleeding associated with use of dabigatran seems to be an example of stimulated reporting and may not represent an increased bleeding risk.
News
Oral Anticoagulants Compared for Gastrointestinal Safety
The researchers found the risk of GI bleeding was lower for apixaban versus dabigatran or rivaroxaban.
Drug News
Dabigatran vs.Warfarin: New Findings Conflict with FDA Analysis
Dabigatran is associated with higher risks of major bleeding and gastrointestinal bleeding compared with warfarin, but patients taking dabigatran also have a reduced risk of intracranial bleeding compared with those taking warfarin, according to new research.
Drug News
Study: Dabigatran vs. Warfarin for Nonvalvular A-Fib
Linked to lower risk of intracranial bleeding, but higher risk of gastrointestinal bleeding
News
Dabigatran Does Not Beat Aspirin for Preventing Recurrent Stroke
Efficacy similar to aspirin for preventing recurrent stroke after embolic stroke of undetermined source
News
Extended Dabigatran Effective for Venous Thromboembolism
For patients with venous thromboembolism, extended treatment with dabigatran is noninferior to warfarin.
News
Safety of Rivaroxaban Compared to Dabigatran in Older A-fib Patients
Increase in risk of intracranial hemorrhage, major GI bleeding in a-fib patients taking rivaroxaban
